-
Mashup Score: 0Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options - Tempus - 2 year(s) ago
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not be the most active first line for the primary disease. The Tempus Tumor Origin (TO) test is a machine learning classifier that uses RNA-Seq data to identify the most likely … Continued
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options - Tempus - 2 year(s) ago
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not be the most active first line for the primary disease. The Tempus Tumor Origin (TO) test is a machine learning classifier that uses RNA-Seq data to identify the most likely … Continued
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Molecular Classification of Cancers of Unknown Primary Expands and Refines Treatment Options - Tempus - 2 year(s) ago
Background: Patients with cancer of unknown primary (CUP) have a poor prognosis due to delays in diagnostic workup and empirically-selected platinum-based regimens that may not be the most active first line for the primary disease. The Tempus Tumor Origin (TO) test is a machine learning classifier that uses RNA-Seq data to identify the most likely … Continued
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4Job - Tempus - 2 year(s) ago
All Content Copyright 2022| Privacy Policy| Notice of Privacy Practices| Terms of Use
Source: TempusCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Study Confirms That Americans Neglected Their Healthcare During COVID-19 Pandemic - Tempus - 3 year(s) ago
Study shows how many Americans neglected healthcare during the pandemic
Source: TempusCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
Molecular classification of cancers of unknown primary expands and refines treatment options [Sep 11, 2022] George et al. #ESMO22 Poster 923P https://t.co/Ha5SUb8GOT & https://t.co/6vxGpOvDFh #PrecisionMedicine #CUPsm @TempusLabs